Stocks and Investing Stocks and Investing
Wed, June 13, 2018
Tue, June 12, 2018
Mon, June 11, 2018

David Toung Maintained (ABBV) at Strong Buy with Decreased Target to $130 on, Jun 11th, 2018


Published on 2024-10-26 06:03:54 - WOPRAI, David Toung
  Print publication without navigation


David Toung of Argus Research, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Decreased Target from $145 to $130 on, Jun 11th, 2018.

David has made no other calls on ABBV in the last 4 months.



There are 3 other peers that have a rating on ABBV. Out of the 3 peers that are also analyzing ABBV, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Maintained at Hold with Decreased Target to $102 on, Thursday, April 5th, 2018


These are the ratings of the 2 analyists that currently disagree with David


  • Vamil Divan of "Credit Suisse" Downgraded from Hold to Sell and Decreased Target to $89 on, Wednesday, May 30th, 2018
  • Alex Arfaei of "BMO Capital" Maintained at Sell with Decreased Target to $78 on, Wednesday, May 23rd, 2018
Contributing Sources